Drreddys Laboratories | RDY - Devedores Comerciais





Devedores Comerciais Alterar Data
ANI Pharmaceuticals USD 274.47M 19.04M 2026-06
Aurora Cannabis CAD 44.58M 3.68M 2026-03
Bayer EUR 18.55B 4.36B 2026-03
Canopy Growth CAD 36.29M 104.13M 2026-03
Cipla INR 62.19B 12.42B 2026-03
Corcept Therapeutics USD 76.92M 37.85M 2026-06
Drreddys Laboratories INR 123.17B 121.76B 2026-03
GlaxoSmithKline GBP 8.07B 137M 2026-06
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Lonza CHF 1.78B 55M 2025-12
Novartis USD 9.85B 252M 2026-06
Pacira USD 132.42M 6.78M 2026-06
Phibro Animal Health USD 215.87M 2.02M 2025-12
Prestige Brands USD 187.36M 4.56M 2026-06
Richter Gedeon HUF 250.25B 5.43B 2026-03
Sun Pharmaceuticals INR 162.09B 5.05B 2026-03
Supernus Pharmaceuticals USD 211.66M 29.47M 2026-06
Teva Pharmaceutical Industries USD 3.49B 100M 2026-06